Doyle Mittie Insider Trading Activity
Doyle Mittie has been net-selling over the last 12 months with 0 purchases and 11 sales across 1 company.
AVTX is the most-traded position with 11 trades. The largest single transaction was a sale of AVTX for $953K on May 6, 2026.
Performance Scorecard
Forward stock performance after each transaction by Doyle Mittie. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +21.9% | 91% | 11 |
| 90 days | — | -5.6% | 33% | 3 |
| 120 days | — | -14.1% | 0% | 1 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersAVTX · Avalo Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Doyle Mittie bought and sold AVTX.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jun 23, 2026 | AVTX | Sell | 1,450 | $18.00 | $26K | −2.7% | Chief Medical Officer | |
May 15, 2026 | AVTX | Sell | 3,000 | $18.76 | $56K | −45.3% | Chief Medical Officer | |
May 6, 2026 | AVTX | Sell | 27,538 | $18.03 | $496K | −25.0% | Chief Medical Officer | |
May 6, 2026 | AVTX | Sell | 5,000 | $19.65 | $98K | −6.1% | Chief Medical Officer | |
May 6, 2026 | AVTX | Sell | 44,944 | $21.20 | $953K | −57.9% | Chief Medical Officer | |
May 6, 2026 | AVTX | Sell | 19,015 | $22.41 | $426K | −58.2% | Chief Medical Officer | |
May 6, 2026 | AVTX | Sell | 10,058 | $22.88 | $230K | −73.5% | Chief Medical Officer | |
May 5, 2026 | AVTX | Sell | 1,679 | $16.00 | $27K | −31.7% | Chief Medical Officer | |
Apr 6, 2026 | AVTX | Sell | 3,970 | $18.01 | $72K | −52.3% | Chief Medical Officer | |
Apr 1, 2026 | AVTX | Sell | 679 | $16.00 | $11K | −15.8% | Chief Medical Officer | |
Mar 16, 2026 | AVTX | Sell | 25,492 | $16.15 | $412K | −87.6% | Chief Medical Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | 11 | $2.8M |
Other insiders at Avalo Therapeutics, Inc.
2 other tracked filers at AVTX.